Gene · 5916
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA modification: mechanisms and therapeutic targets. | Mol Biomed | 2023 | 37612540 | PubTator, text mining | PubMed |
| Recurrent RARG trinary fusion and ligand binding domain truncation in variant acute promyelocytic leukemia resistant to retinoic acid but sensitive to homoharringtonine-based therapy. | Int J Lab Hematol | 2023 | 37605819 | PubTator, text mining | PubMed |
| Targeting nuclear hormone receptors for the prevention of breast cancer. | Front Med (Lausanne) | 2023 | 37583424 | PubTator, text mining | PubMed |
| Human nutritional relevance and suggested nutritional guidelines for vitamin A5/X and provitamin A5/X. | Nutr Metab (Lond) | 2023 | 37582723 | PubTator, text mining | PubMed |
| Tectorigenin: A Review of Its Sources, Pharmacology, Toxicity, and Pharmacokinetics. | Molecules | 2023 | 37570873 | PubTator, text mining | PubMed |
| Corneal Endothelial-like Cells Derived from Induced Pluripotent Stem Cells for Cell Therapy. | Int J Mol Sci | 2023 | 37569804 | PubTator, text mining | PubMed |
| Deregulation of All-Trans Retinoic Acid Signaling and Development in Cancer. | Int J Mol Sci | 2023 | 37569466 | PubTator, text mining | PubMed |
| BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution. | Theranostics | 2023 | 37554265 | PubTator, text mining | PubMed |
| Novel Therapeutic Targets for Fibrodysplasia Ossificans Progressiva: Emerging Strategies and Future Directions. | Cureus | 2023 | 37521595 | PubTator, text mining | PubMed |
| Derivation and characteristics of induced pluripotent stem cells from a patient with acute myelitis. | Front Cell Dev Biol | 2023 | 37519296 | PubTator, text mining | PubMed |
| Editorial: Special Issue "Stem Cell Biology and Cancer". | Int J Mol Sci | 2023 | 37511301 | PubTator, text mining | PubMed |
| The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away. | Cancers (Basel) | 2023 | 37509198 | PubTator, text mining | PubMed |
| Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring. | Eur Heart J Cardiovasc Imaging | 2023 | 37467476 | PubTator, text mining | PubMed |
| Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment. | Mediators Inflamm | 2023 | 37457746 | PubTator, text mining | PubMed |
| Integrated multiomic analysis and high-throughput screening reveal potential gene targets and synergetic drug combinations for osteosarcoma therapy. | MedComm (2020) | 2023 | 37457661 | PubTator, text mining | PubMed |
| Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition. | Cancers (Basel) | 2023 | 37444447 | PubTator, text mining | PubMed |
| New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review. | Cancers (Basel) | 2023 | 37444400 | PubTator, text mining | PubMed |
| The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling. | Cells | 2023 | 37443730 | PubTator, text mining | PubMed |
| Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II. | Front Oncol | 2023 | 37441418 | PubTator, text mining | PubMed |
| A critical role for heme synthesis and succinate in the regulation of pluripotent states transitions. | Elife | 2023 | 37428012 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5916/papers?page=9